TY - JOUR
T1 - The contribution of X-linked coding variation to severe developmental disorders
AU - Martin, Hilary C.
AU - Gardner, Eugene J.
AU - Samocha, Kaitlin E.
AU - Kaplanis, Joanna
AU - Akawi, Nadia
AU - Sifrim, Alejandro
AU - Eberhardt, Ruth Y.
AU - Tavares, Ana Lisa Taylor
AU - Neville, Matthew D. C.
AU - Niemi, Mari E. K.
AU - Gallone, Giuseppe
AU - McRae, Jeremy
AU - Borras, Silvia
AU - Clark, Caroline
AU - Dean, John
AU - Miedzybrodzka, Zosia
AU - Ross, Alison
AU - Tennant, Stephen
AU - Dabir, Tabib
AU - Donnelly, Deirdre
AU - Humphreys, Mervyn
AU - Magee, Alex
AU - McConnell, Vivienne
AU - McKee, Shane
AU - McNerlan, Susan
AU - Morrison, Patrick J.
AU - Rea, Gillian
AU - Stewart, Fiona
AU - Cole, Trevor
AU - Cooper, Nicola
AU - Cooper-Charles, Lisa
AU - Cox, Helen
AU - Islam, Lily
AU - Jarvis, Joanna
AU - Keelagher, Rebecca
AU - Lim, Derek
AU - McMullan, Dominic
AU - Morton, Jenny
AU - Naik, Swati
AU - O’Driscoll, Mary
AU - Ong, Kai Ren
AU - Osio, Deborah
AU - Ragge, Nicola
AU - Berg, Jonathan
AU - Goudie, David
AU - McWilliam, Catherine
AU - Jackson, Andrew
AU - Gardiner, Carol
AU - Ellis, Ian
AU - Stewart, Alison
AU - Wright, Caroline F.
AU - Fitzpatrick, David R.
AU - Firth, Helen V.
AU - Hurles, Matthew E.
N1 - Funding Information:
We thank the DDD families for participating, the DDD clinicians for recruiting patients, the Sanger Sample Management and Sequencing pipelines teams for generating the data, the Sanger Human Genome Informatics team for helping to process the exome data, and Nicola Whiffin for helpful comments on the manuscript. The study was approved by the UK Research Ethics Committee (10/H0305/83, granted by the Cambridge South Research Ethics Committee and GEN/284/12, granted by the Republic of Ireland Research Ethics Committee). This work has been conducted using the UK Biobank Resource under Application Number 44165. The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the UK Department of Health, and the Wellcome Trust Sanger Institute (grant WT098051). The views expressed in this publication are those of the author(s) and not necessarily those of the Wellcome Trust or the UK Department of Health. The study has UK Research Ethics Committee approval (10/H0305/83, granted by the Cambridge South Research Ethics Committee and GEN/284/12, granted by the Republic of Ireland Research Ethics Committee). The research team acknowledges the support of the National Institutes for Health Research, through the Comprehensive Clinical Research Network. This study makes use of DECIPHER (http://decipher.sanger.ac.uk), which is funded by the Wellcome Trust.
Publisher Copyright:
© 2021, The Author(s).
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/12
Y1 - 2021/12
N2 - Over 130 X-linked genes have been robustly associated with developmental disorders, and X-linked causes have been hypothesised to underlie the higher developmental disorder rates in males. Here, we evaluate the burden of X-linked coding variation in 11,044 developmental disorder patients, and find a similar rate of X-linked causes in males and females (6.0% and 6.9%, respectively), indicating that such variants do not account for the 1.4-fold male bias. We develop an improved strategy to detect X-linked developmental disorders and identify 23 significant genes, all of which were previously known, consistent with our inference that the vast majority of the X-linked burden is in known developmental disorder-associated genes. Importantly, we estimate that, in male probands, only 13% of inherited rare missense variants in known developmental disorder-associated genes are likely to be pathogenic. Our results demonstrate that statistical analysis of large datasets can refine our understanding of modes of inheritance for individual X-linked disorders.
AB - Over 130 X-linked genes have been robustly associated with developmental disorders, and X-linked causes have been hypothesised to underlie the higher developmental disorder rates in males. Here, we evaluate the burden of X-linked coding variation in 11,044 developmental disorder patients, and find a similar rate of X-linked causes in males and females (6.0% and 6.9%, respectively), indicating that such variants do not account for the 1.4-fold male bias. We develop an improved strategy to detect X-linked developmental disorders and identify 23 significant genes, all of which were previously known, consistent with our inference that the vast majority of the X-linked burden is in known developmental disorder-associated genes. Importantly, we estimate that, in male probands, only 13% of inherited rare missense variants in known developmental disorder-associated genes are likely to be pathogenic. Our results demonstrate that statistical analysis of large datasets can refine our understanding of modes of inheritance for individual X-linked disorders.
KW - Genetic association study
KW - Medical genetics
KW - Neurodevelopmental disorders
UR - http://www.scopus.com/inward/record.url?scp=85099943870&partnerID=8YFLogxK
U2 - 10.1038/s41467-020-20852-3
DO - 10.1038/s41467-020-20852-3
M3 - Article
C2 - 33504798
AN - SCOPUS:85099943870
SN - 2041-1723
VL - 12
JO - Nature Communications
JF - Nature Communications
M1 - 627
ER -